BioTherapeutics Inc.
Innovative small-molecule drugs for inflammation in autoimmune disorders and type 2 diabetes.
4 employees · est. 2008 · Blacksburg, United States
BioTherapeutics Inc. is the older company (2008 vs 2013); TISSIUM is the larger of the two.
Side-by-Side Comparison
| Metric | BioTherapeutics Inc. | TISSIUM |
|---|---|---|
| Founded | ||
| Founded | 2008 older | 2013 |
| Headquarters | ||
| Headquarters | Blacksburg, United States | Paris, France |
| Employees | ||
| Employees | 4 | 132 larger |
| Industry | ||
| Industry | Biotechnology, Health Care | Biotechnology, Health Care, Medical Devices |
| Funding Stage | ||
| Funding Stage | Grant | Series D |
| Total Funding | ||
| Total Funding | $800.00K | $215.20M |
| Funding Rounds | ||
| Funding Rounds | 2 | 11 |
| Services | ||
| Services | Not tracked yet | development and production of biomorphic programmable polymers for tissue reconstruction |
| Target Customers | ||
| Target Customers | Not tracked yet | healthcare institutions, surgeons, medical professionals |
| Taxonomy | ||
| Taxonomy | Small-molecule Drugs, Inflammation, Autoimmune Disorders, Type 2 Diabetes, Precision Medicine, Computational Modeling, Artificial Intelligence, Translational Experimentation, Pre-clinical Stage, Biomedical Data, Technology Innovations, Health Solutions | Medical Device, MedTech, Synthetic Polymers, Tissue Reconstruction, Biodegradable Sealants, Wound Closure, Minimally Invasive Surgery, Innovation, Research And Development, Biomedical Engineering, Biomedical Materials, Polymer Science, Surgical Adhesives, Biomedical Innovation |
| Website | ||
| Website | biotherapeuticsinc.com | tissium.com |
About BioTherapeutics Inc.
BioTherapeutics Inc. (BTI) is a biotechnology startup that is dedicated to developing innovative small-molecule drugs for inflammation in autoimmune disorders and type 2 diabetes. With the slogan "Innovative small-molecule drugs for inflammation in autoimmune disorders and type 2 diabetes," BTI aims...
About TISSIUM
TISSIUM is a biotechnology startup with the slogan "Biomorphic Programmable Polymers," initially established in 2013 in France. The company's core objective is to address the persistent medical challenge of tissue reconstruction and restoration of natural function. Their groundbreaking technology, f...
We will tell you when either one moves
BounceWatch watches BioTherapeutics Inc. and TISSIUM for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at BioTherapeutics Inc. and TISSIUM — by email.
Frequently Asked Questions
Compare BioTherapeutics Inc. with someone else
Start typing a company name or domain.
Related Comparisons
Compiled from the BounceWatch company index. We last looked at BioTherapeutics Inc. on 14 Sep 2024, and TISSIUM on 11 Jun 2025. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
